Cargando…

The Association between Liver Enzymes and Mortality Stratified by Non-Alcoholic Fatty Liver Disease: An Analysis of NHANES III

Associations between liver enzymes or De Ritis ratio (DRR; aspartate aminotransferase (AST)/alanine aminotransferase (ALT)) and mortality stratified by non-alcoholic fatty liver disease (NAFLD), which have rarely been analyzed in previous studies, were investigated using the National Health and Nutr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grob, Saskia Rita, Suter, Flurina, Katzke, Verena, Rohrmann, Sabine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10346959/ https://www.ncbi.nlm.nih.gov/pubmed/37447388 http://dx.doi.org/10.3390/nu15133063

Ejemplares similares

Alcohol consumption: context and association with mortality in Switzerland
por: Suter, Flurina, et al.
Publicado: (2022)

Serum leptin, C‐reactive protein, and cancer mortality in the NHANES III
por: Wulaningsih, Wahyu, et al.
Publicado: (2015)

Phenotypes of non-alcoholic fatty liver disease (NAFLD) and all-cause mortality: unsupervised machine learning analysis of NHANES III
por: Carrillo-Larco, Rodrigo M, et al.
Publicado: (2022)

Is Following a Cancer-Protective Lifestyle Linked to Reduced Cancer Mortality Risk?
por: Suter, Flurina, et al.
Publicado: (2023)

The Relationship between Nonalcoholic Fatty Liver Disease and Retinopathy in NHANES III
por: Lin, Tzu-Yu, et al.
Publicado: (2016)

Role of fatty liver index in risk-stratifying comorbid disease outcomes in non-alcoholic fatty liver disease
por: Ho, Brian, et al.
Publicado: (2023)

Calcium Intake and Serum Concentration in Relation to Risk of Cardiovascular Death in NHANES III
por: Van Hemelrijck, Mieke, et al.
Publicado: (2013)

Association Between Pulmonary Function and Nonalcoholic Fatty Liver Disease in the NHANES III Study
por: Peng, Tao-Chun, et al.
Publicado: (2015)

Associations of metal mixtures with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2003–2018
por: Xie, Zhilan, et al.
Publicado: (2023)

Healthy lifestyle is inversely associated with mortality in cancer survivors: Results from the Third National Health and Nutrition Examination Survey (NHANES III)
por: Karavasiloglou, Nena, et al.
Publicado: (2019)

Circulating liver enzymes and risks of chronic diseases and mortality in the prospective EPIC-Heidelberg case-cohort study
por: Katzke, Verena, et al.
Publicado: (2020)

Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease
por: Sinha, Rohit, et al.
Publicado: (2020)

Ability of a biomarker-based score to predict death from circulatory disease and cancer in NHANES III
por: Van Hemelrijck, Mieke, et al.
Publicado: (2012)

The association between circulating IGF1, IGFBP3, and calcium: results from NHANES III
por: Van Hemelrijck, Mieke, et al.
Publicado: (2015)

Post-Diagnostic Diet Quality and Mortality in Females with Self-Reported History of Breast or Gynecological Cancers: Results from the Third National Health and Nutrition Examination Survey (NHANES III)
por: Karavasiloglou, Nena, et al.
Publicado: (2019)

Dietary Carotenoids and Non-Alcoholic Fatty Liver Disease among US Adults, NHANES 2003–2014
por: Christensen, Krista, et al.
Publicado: (2019)

The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database
por: Alkhouri, Naim, et al.
Publicado: (2022)

Association of serum folate with prevalence of non-alcoholic fatty liver disease among adults (NHANES 2011–2018)
por: Yao, Baodong, et al.
Publicado: (2023)

Association of weight-adjusted-waist index with non-alcoholic fatty liver disease and liver fibrosis: a cross-sectional study based on NHANES
por: Hu, Qinggang, et al.
Publicado: (2023)

Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation
por: Gallego-Durán, Rocío, et al.
Publicado: (2022)

Comparison of Cardiovascular Procedure Rates in Patients With Supplementary vs Basic Insurance in Switzerland
por: Struja, Tristan, et al.
Publicado: (2023)

Bisphenol a increases risk for presumed non-alcoholic fatty liver disease in Hispanic adolescents in NHANES 2003–2010
por: Verstraete, Sofia G., et al.
Publicado: (2018)

Machine learning models for predicting non-alcoholic fatty liver disease in the general United States population: NHANES database
por: Atsawarungruangkit, Amporn, et al.
Publicado: (2021)

Glycohemoglobin: A new warning strategy for non-alcoholic fatty liver disease: Study from the NHANES 2017- 2020
por: Hou, Jiaxing, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States
por: Paik, James M., et al.
Publicado: (2020)

The growing burden of non-alcoholic fatty liver disease on mortality
por: Cho, Ju-Yeon, et al.
Publicado: (2023)

The effect of an aerobic exercise on serum level of liver enzymes and liver echogenicity in patients with non alcoholic fatty liver disease
por: Khaoshbaten, Manochehr, et al.
Publicado: (2013)

Associations of serum carotenoid concentrations and fruit or vegetable consumption with serum insulin-like growth factor (IGF)-1 and IGF binding protein-3 concentrations in the Third National Health and Nutrition Examination Survey (NHANES III)
por: Diener, Anja, et al.
Publicado: (2016)

Effects of lifestyle modification on liver enzyme and Fibroscan in Indian patients with non-alcoholic fatty liver disease
por: Paul, Jayanta, et al.
Publicado: (2018)

Elevated Liver Enzymes in Patients with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease
por: Mandal, Amrendra, et al.
Publicado: (2018)

Bariatric Metabolic Surgery Reduced Liver Enzyme Levels in Patients with Non-Alcohol Fatty Liver Disease
por: Kirkpatrick, Kennedy, et al.
Publicado: (2021)

Effect of pemafibrate on liver enzymes and shear wave velocity in non-alcoholic fatty liver disease patients
por: Sugimoto, Ryosuke, et al.
Publicado: (2023)

Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
por: Jung, Han Na, et al.
Publicado: (2023)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease()
por: Khambu, Bilon, et al.
Publicado: (2018)

Diagnostic ability using fatty liver and metabolic markers for metabolic‐associated fatty liver disease stratified by metabolic/glycemic abnormalities
por: Okada, Akira, et al.
Publicado: (2022)

Ketogenic Diet-induced Elevated Cholesterol, Elevated Liver Enzymes and Potential Non-alcoholic Fatty Liver Disease
por: Anekwe, Chika V, et al.
Publicado: (2020)

Silymarin treatment and reduction of liver enzyme levels in non-alcoholic fatty liver disease: a case report
por: Chantarojanasiri, Tanyaporn
Publicado: (2023)

Non-alcoholic fatty liver disease and liver secretome
por: Khan, Muhammad Sohaib, et al.
Publicado: (2022)

The association between non-alcoholic fatty liver disease (NAFLD) and advanced fibrosis with blood selenium level based on the NHANES 2017-2018
por: Liu, Jie, et al.
Publicado: (2022)

The Impact of Insulin Resistance on Hepatic Fibrosis among United States Adults with Non-Alcoholic Fatty Liver Disease: NHANES 2017 to 2018
por: Bae, Ji Cheol, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_491tc6v8kg1i61vipln3jod127